NCT02431676 2024-08-28SPIRITSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed121 enrolled 12 charts
NCT03685591 2024-06-26PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsPfizerPhase 1 Terminated49 enrolled 33 charts
NCT05061537 2024-04-12Study of PF-07263689 in Participants With Selected Advanced Solid TumorsPfizerPhase 1 Terminated13 enrolled 16 charts
NCT02315066 2022-04-21Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566PfizerPhase 1 Completed174 enrolled 68 charts
NCT01967823 2021-03-24T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing CancerNational Institutes of Health Clinical Center (CC)Phase 2 Completed11 enrolled 12 charts